Efficiency of code blue in a tertiary care hospital: A lesson we learned Code blue in a tertiary care hospital

View/ Open
Date
2019Author
OFLAZ, Ali
ÇALIK, Saniye Göknil
ÇALIK, Mustafa
ARSLAN KAŞDOĞAN, Zümrüt Ela
KALENDER, Mehmet
DAĞLI, Mustafa
Metadata
Show full item recordAbstract
Aim: Code Blue (CB) is an emergency that requires appropriate sequential
actions gained through training with organized teamwork. This research
has been conducted to evaluate the efficacy, efficiency, and application
results of code blue which is used in our hospital. Material and Method:
CB was called between years 2014 and 2015 and 303 patients were examined
retrospectively. Results: The mean age of the patients was 68.74 (range
24-92), the number of female patients was 157 (51.81\%), and male
patients was 146 (48.19\%). The mean time to reach the patient was 2.83
+/- 1.15 (range: 0.16-8.53) minutes, and the time when most CB were
called was between 13.00 and 15.00 pm (p>0.059). CB calls were most
commonly made from neurosurgery, neurology, and respiratory intensive
care units. The most often CB calls were made on weekdays (p>0.05). Sex
was not associated with mortality (p>0.05). Worst outcome was associated
with the outpatient ward, nephrology ward, nephrology ICU, and
obstetrics ward (p<0.05). CB team's reaching time to the patient was not
associated with mortality (p>0.05). Time of CB calls was associated with
mortality. Worst outcome was observed during 01:00 to 06:00 am (p<0.05).
Mortality was observed in patients who have received a statistically
significant longer period of CPR (p<0.05). Discussion: The outcome of CB
call is particularly dependent on critical interventions. Although the
time to reach our patients was similar to the literature values,
survival rate will be increased by the providing continuous CPR training
for all hospital staff at intervals not longer than 6 months for the
intervention to be performed until the arrival of the CB team.
Collections

DSpace@Karatay by Karatay University Institutional Repository is licensed under a Creative Commons Attribution-NonCommercial-NoDerivs 4.0 Unported License..